Last update 21 Nov 2024
Buspirone/Carbidopa/Levodopa
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Buspirone/levodopa/carbidopa, Spinalon |
Mechanism 5-HT1A receptor partial agonists(Serotonin 1a (5-HT1a) receptor partial agonists), D2 receptor antagonists(Dopamine D2 receptor antagonists), DDC inhibitors(DOPA decarboxylase inhibitors) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC10H16N2O5 |
InChIKeyQTAOMKOIBXZKND-PPHPATTJSA-N |
CAS Registry38821-49-7 |
View All Structures (3)
Related
1
Clinical Trials associated with Buspirone/Carbidopa/LevodopaTri-therapy (SPINALON)-Elicited Spinal Locomotor Network Activation: Phase I-IIa Clinical Trial in Patients With Chronic Spinal Cord Injury
100 Clinical Results associated with Buspirone/Carbidopa/Levodopa
Login to view more data
100 Translational Medicine associated with Buspirone/Carbidopa/Levodopa
Login to view more data
100 Patents (Medical) associated with Buspirone/Carbidopa/Levodopa
Login to view more data
100 Deals associated with Buspirone/Carbidopa/Levodopa
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Sclerosis | Phase 2 | - | - | |
| Multiple Sclerosis | Phase 2 | - | - | |
| Multiple Sclerosis | Phase 2 | - | - | |
| Spinal Cord Injuries | Phase 2 | - | - | |
| Spinal Cord Injuries | Phase 2 | - | - | |
| Spinal Cord Injuries | Phase 2 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free